116PA targeted genomic analysis uncovered a large spectrum of acquired resistance mechanisms to BRAF inhibitor therapy in metastatic melanoma patients. (5th March 2018) - Louveau, B; Reger de Moura, C; Battistella, M; Sadoux, A; Chami, I; Caramel, J; Dalle, S; Dumaz, N; Lebbe, C; Mourah, S